カテゴリ： 世界, 医療/バイオ, Market Monitor Global

組換えIII型コラーゲンのグローバル市場展望 2023年-2029年：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他

■ 英語タイトル：Recombinant Type III Collagen Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC13748）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC13748
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：75
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[組換えIII型コラーゲンのグローバル市場展望 2023年-2029年：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の組換えIII型コラーゲン市場規模と予測を収録しています。・世界の組換えIII型コラーゲン市場：売上、2018年-2023年、2024年-2029年
・世界の組換えIII型コラーゲン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の組換えIII型コラーゲン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「組換えIII型コラーゲンフリーズドライファイバー」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

組換えIII型コラーゲンのグローバル主要企業は、Novus Biologicals、 Evonik Industries、 Advanced BioMatrix、 SNIME、 Shanxi Jinbo Bio-Pharmaceutical、 R&D Systems、 BAHE、 Harbin Fuerjia Technology、 Beijing Duomeikang Medical Science and Technology、 Yangzhou Meirui Biologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、組換えIII型コラーゲンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の組換えIII型コラーゲン市場：タイプ別、2018年-2023年、2024年-2029年
世界の組換えIII型コラーゲン市場：タイプ別市場シェア、2022年
・組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他

世界の組換えIII型コラーゲン市場：用途別、2018年-2023年、2024年-2029年
世界の組換えIII型コラーゲン市場：用途別市場シェア、2022年
・軟骨修復材、人工皮膚製造、膣疾患治療、傷跡予防、その他

世界の組換えIII型コラーゲン市場：地域・国別、2018年-2023年、2024年-2029年
世界の組換えIII型コラーゲン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における組換えIII型コラーゲンのグローバル売上、2018年-2023年
・主要企業における組換えIII型コラーゲンのグローバル売上シェア、2022年
・主要企業における組換えIII型コラーゲンのグローバル販売量、2018年-2023年
・主要企業における組換えIII型コラーゲンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novus Biologicals、 Evonik Industries、 Advanced BioMatrix、 SNIME、 Shanxi Jinbo Bio-Pharmaceutical、 R&D Systems、 BAHE、 Harbin Fuerjia Technology、 Beijing Duomeikang Medical Science and Technology、 Yangzhou Meirui Biology

*************************************************************

・調査・分析レポートの概要
組換えIII型コラーゲン市場の定義
市場セグメント
世界の組換えIII型コラーゲン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の組換えIII型コラーゲン市場規模
世界の組換えIII型コラーゲン市場規模：2022年 VS 2029年
世界の組換えIII型コラーゲン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの組換えIII型コラーゲンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の組換えIII型コラーゲン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他
組換えIII型コラーゲンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：軟骨修復材、人工皮膚製造、膣疾患治療、傷跡予防、その他
組換えIII型コラーゲンの用途別グローバル売上・予測

・地域別市場分析
地域別組換えIII型コラーゲン市場規模 2022年と2029年
地域別組換えIII型コラーゲン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Novus Biologicals、 Evonik Industries、 Advanced BioMatrix、 SNIME、 Shanxi Jinbo Bio-Pharmaceutical、 R&D Systems、 BAHE、 Harbin Fuerjia Technology、 Beijing Duomeikang Medical Science and Technology、 Yangzhou Meirui Biology
...

This research report provides a comprehensive analysis of the Recombinant Type III Collagen market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Recombinant Type III Collagen market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Recombinant Type III Collagen, challenges faced by the industry, and potential opportunities for market players.
The global Recombinant Type III Collagen market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Recombinant Type III Collagen market presents opportunities for various stakeholders, including Cartilage Repair Materials, Artificial Skin Manufacturing. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Recombinant Type III Collagen market. Additionally, the growing consumer demand present avenues for market expansion.
The global Recombinant Type III Collagen market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Recombinant Type III Collagen market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Recombinant Type III Collagen market.
Market Overview: The report provides a comprehensive overview of the Recombinant Type III Collagen market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Recombinant Type III Collagen Freeze-Dried Fiber, Complex Recombinant Type III Collagen Dressing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Recombinant Type III Collagen market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Recombinant Type III Collagen market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Recombinant Type III Collagen market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Recombinant Type III Collagen market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Recombinant Type III Collagen market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Recombinant Type III Collagen market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Recombinant Type III Collagen, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Recombinant Type III Collagen market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Recombinant Type III Collagen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Recombinant Type III Collagen Freeze-Dried Fiber
Complex Recombinant Type III Collagen Dressing
Recombinant Type III Collagen Gel
Other
Market segment by Application
Cartilage Repair Materials
Artificial Skin Manufacturing
Treatment Of Vaginal Disorders
Scar Prevention
Other
Global Recombinant Type III Collagen Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novus Biologicals
Evonik Industries
Advanced BioMatrix
SNIME
Shanxi Jinbo Bio-Pharmaceutical
R&D Systems
BAHE
Harbin Fuerjia Technology
Beijing Duomeikang Medical Science and Technology
Yangzhou Meirui Biology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Type III Collagen, market overview.
Chapter 2: Global Recombinant Type III Collagen market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Type III Collagen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Type III Collagen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Type III Collagen capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Recombinant Type III Collagen Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Type III Collagen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Type III Collagen Overall Market Size
2.1 Global Recombinant Type III Collagen Market Size: 2022 VS 2029
2.2 Global Recombinant Type III Collagen Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Type III Collagen Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Type III Collagen Players in Global Market
3.2 Top Global Recombinant Type III Collagen Companies Ranked by Revenue
3.3 Global Recombinant Type III Collagen Revenue by Companies
3.4 Global Recombinant Type III Collagen Sales by Companies
3.5 Global Recombinant Type III Collagen Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Type III Collagen Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Type III Collagen Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Type III Collagen Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Type III Collagen Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Type III Collagen Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Type III Collagen Market Size Markets, 2022 & 2029
4.1.2 Recombinant Type III Collagen Freeze-Dried Fiber
4.1.3 Complex Recombinant Type III Collagen Dressing
4.1.4 Recombinant Type III Collagen Gel
4.1.5 Other
4.2 By Type – Global Recombinant Type III Collagen Revenue & Forecasts
4.2.1 By Type – Global Recombinant Type III Collagen Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Type III Collagen Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
4.3 By Type – Global Recombinant Type III Collagen Sales & Forecasts
4.3.1 By Type – Global Recombinant Type III Collagen Sales, 2018-2023
4.3.2 By Type – Global Recombinant Type III Collagen Sales, 2024-2029
4.3.3 By Type – Global Recombinant Type III Collagen Sales Market Share, 2018-2029
4.4 By Type – Global Recombinant Type III Collagen Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Type III Collagen Market Size, 2022 & 2029
5.1.2 Cartilage Repair Materials
5.1.3 Artificial Skin Manufacturing
5.1.4 Treatment Of Vaginal Disorders
5.1.5 Scar Prevention
5.1.6 Other
5.2 By Application – Global Recombinant Type III Collagen Revenue & Forecasts
5.2.1 By Application – Global Recombinant Type III Collagen Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Type III Collagen Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
5.3 By Application – Global Recombinant Type III Collagen Sales & Forecasts
5.3.1 By Application – Global Recombinant Type III Collagen Sales, 2018-2023
5.3.2 By Application – Global Recombinant Type III Collagen Sales, 2024-2029
5.3.3 By Application – Global Recombinant Type III Collagen Sales Market Share, 2018-2029
5.4 By Application – Global Recombinant Type III Collagen Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Type III Collagen Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Type III Collagen Revenue & Forecasts
6.2.1 By Region – Global Recombinant Type III Collagen Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Type III Collagen Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
6.3 By Region – Global Recombinant Type III Collagen Sales & Forecasts
6.3.1 By Region – Global Recombinant Type III Collagen Sales, 2018-2023
6.3.2 By Region – Global Recombinant Type III Collagen Sales, 2024-2029
6.3.3 By Region – Global Recombinant Type III Collagen Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Recombinant Type III Collagen Revenue, 2018-2029
6.4.2 By Country – North America Recombinant Type III Collagen Sales, 2018-2029
6.4.3 US Recombinant Type III Collagen Market Size, 2018-2029
6.4.4 Canada Recombinant Type III Collagen Market Size, 2018-2029
6.4.5 Mexico Recombinant Type III Collagen Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Recombinant Type III Collagen Revenue, 2018-2029
6.5.2 By Country – Europe Recombinant Type III Collagen Sales, 2018-2029
6.5.3 Germany Recombinant Type III Collagen Market Size, 2018-2029
6.5.4 France Recombinant Type III Collagen Market Size, 2018-2029
6.5.5 U.K. Recombinant Type III Collagen Market Size, 2018-2029
6.5.6 Italy Recombinant Type III Collagen Market Size, 2018-2029
6.5.7 Russia Recombinant Type III Collagen Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Type III Collagen Market Size, 2018-2029
6.5.9 Benelux Recombinant Type III Collagen Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Recombinant Type III Collagen Revenue, 2018-2029
6.6.2 By Region – Asia Recombinant Type III Collagen Sales, 2018-2029
6.6.3 China Recombinant Type III Collagen Market Size, 2018-2029
6.6.4 Japan Recombinant Type III Collagen Market Size, 2018-2029
6.6.5 South Korea Recombinant Type III Collagen Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Type III Collagen Market Size, 2018-2029
6.6.7 India Recombinant Type III Collagen Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Recombinant Type III Collagen Revenue, 2018-2029
6.7.2 By Country – South America Recombinant Type III Collagen Sales, 2018-2029
6.7.3 Brazil Recombinant Type III Collagen Market Size, 2018-2029
6.7.4 Argentina Recombinant Type III Collagen Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Recombinant Type III Collagen Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Recombinant Type III Collagen Sales, 2018-2029
6.8.3 Turkey Recombinant Type III Collagen Market Size, 2018-2029
6.8.4 Israel Recombinant Type III Collagen Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Type III Collagen Market Size, 2018-2029
6.8.6 UAE Recombinant Type III Collagen Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novus Biologicals
7.1.1 Novus Biologicals Company Summary
7.1.2 Novus Biologicals Business Overview
7.1.3 Novus Biologicals Recombinant Type III Collagen Major Product Offerings
7.1.4 Novus Biologicals Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.1.5 Novus Biologicals Key News & Latest Developments
7.2 Evonik Industries
7.2.1 Evonik Industries Company Summary
7.2.2 Evonik Industries Business Overview
7.2.3 Evonik Industries Recombinant Type III Collagen Major Product Offerings
7.2.4 Evonik Industries Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.2.5 Evonik Industries Key News & Latest Developments
7.3 Advanced BioMatrix
7.3.1 Advanced BioMatrix Company Summary
7.3.2 Advanced BioMatrix Business Overview
7.3.3 Advanced BioMatrix Recombinant Type III Collagen Major Product Offerings
7.3.4 Advanced BioMatrix Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.3.5 Advanced BioMatrix Key News & Latest Developments
7.4 SNIME
7.4.1 SNIME Company Summary
7.4.2 SNIME Business Overview
7.4.3 SNIME Recombinant Type III Collagen Major Product Offerings
7.4.4 SNIME Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.4.5 SNIME Key News & Latest Developments
7.5 Shanxi Jinbo Bio-Pharmaceutical
7.5.1 Shanxi Jinbo Bio-Pharmaceutical Company Summary
7.5.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
7.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Major Product Offerings
7.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.5.5 Shanxi Jinbo Bio-Pharmaceutical Key News & Latest Developments
7.6 R&D Systems
7.6.1 R&D Systems Company Summary
7.6.2 R&D Systems Business Overview
7.6.3 R&D Systems Recombinant Type III Collagen Major Product Offerings
7.6.4 R&D Systems Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.6.5 R&D Systems Key News & Latest Developments
7.7 BAHE
7.7.1 BAHE Company Summary
7.7.2 BAHE Business Overview
7.7.3 BAHE Recombinant Type III Collagen Major Product Offerings
7.7.4 BAHE Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.7.5 BAHE Key News & Latest Developments
7.8 Harbin Fuerjia Technology
7.8.1 Harbin Fuerjia Technology Company Summary
7.8.2 Harbin Fuerjia Technology Business Overview
7.8.3 Harbin Fuerjia Technology Recombinant Type III Collagen Major Product Offerings
7.8.4 Harbin Fuerjia Technology Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.8.5 Harbin Fuerjia Technology Key News & Latest Developments
7.9 Beijing Duomeikang Medical Science and Technology
7.9.1 Beijing Duomeikang Medical Science and Technology Company Summary
7.9.2 Beijing Duomeikang Medical Science and Technology Business Overview
7.9.3 Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Major Product Offerings
7.9.4 Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.9.5 Beijing Duomeikang Medical Science and Technology Key News & Latest Developments
7.10 Yangzhou Meirui Biology
7.10.1 Yangzhou Meirui Biology Company Summary
7.10.2 Yangzhou Meirui Biology Business Overview
7.10.3 Yangzhou Meirui Biology Recombinant Type III Collagen Major Product Offerings
7.10.4 Yangzhou Meirui Biology Recombinant Type III Collagen Sales and Revenue in Global (2018-2023)
7.10.5 Yangzhou Meirui Biology Key News & Latest Developments
8 Global Recombinant Type III Collagen Production Capacity, Analysis
8.1 Global Recombinant Type III Collagen Production Capacity, 2018-2029
8.2 Recombinant Type III Collagen Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Type III Collagen Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Type III Collagen Supply Chain Analysis
10.1 Recombinant Type III Collagen Industry Value Chain
10.2 Recombinant Type III Collagen Upstream Market
10.3 Recombinant Type III Collagen Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Type III Collagen Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Recombinant Type III Collagen in Global Market
Table 2. Top Recombinant Type III Collagen Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Type III Collagen Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Type III Collagen Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Type III Collagen Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Type III Collagen Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Type III Collagen Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Type III Collagen Product Type
Table 9. List of Global Tier 1 Recombinant Type III Collagen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Type III Collagen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Recombinant Type III Collagen Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Type III Collagen Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Type III Collagen Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Type III Collagen Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Type III Collagen Sales (K Units), 2024-2029
Table 16. By Application – Global Recombinant Type III Collagen Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Type III Collagen Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Type III Collagen Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Type III Collagen Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Type III Collagen Sales (K Units), 2024-2029
Table 21. By Region – Global Recombinant Type III Collagen Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Type III Collagen Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Type III Collagen Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Type III Collagen Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Type III Collagen Sales (K Units), 2024-2029
Table 26. By Country - North America Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Type III Collagen Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Type III Collagen Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Type III Collagen Sales, (K Units), 2024-2029
Table 30. By Country - Europe Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Type III Collagen Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Type III Collagen Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Type III Collagen Sales, (K Units), 2024-2029
Table 34. By Region - Asia Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Type III Collagen Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Type III Collagen Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Type III Collagen Sales, (K Units), 2024-2029
Table 38. By Country - South America Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Type III Collagen Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Type III Collagen Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Type III Collagen Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Type III Collagen Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Type III Collagen Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Type III Collagen Sales, (K Units), 2024-2029
Table 46. Novus Biologicals Company Summary
Table 47. Novus Biologicals Recombinant Type III Collagen Product Offerings
Table 48. Novus Biologicals Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novus Biologicals Key News & Latest Developments
Table 50. Evonik Industries Company Summary
Table 51. Evonik Industries Recombinant Type III Collagen Product Offerings
Table 52. Evonik Industries Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Evonik Industries Key News & Latest Developments
Table 54. Advanced BioMatrix Company Summary
Table 55. Advanced BioMatrix Recombinant Type III Collagen Product Offerings
Table 56. Advanced BioMatrix Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Advanced BioMatrix Key News & Latest Developments
Table 58. SNIME Company Summary
Table 59. SNIME Recombinant Type III Collagen Product Offerings
Table 60. SNIME Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. SNIME Key News & Latest Developments
Table 62. Shanxi Jinbo Bio-Pharmaceutical Company Summary
Table 63. Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Product Offerings
Table 64. Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Shanxi Jinbo Bio-Pharmaceutical Key News & Latest Developments
Table 66. R&D Systems Company Summary
Table 67. R&D Systems Recombinant Type III Collagen Product Offerings
Table 68. R&D Systems Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. R&D Systems Key News & Latest Developments
Table 70. BAHE Company Summary
Table 71. BAHE Recombinant Type III Collagen Product Offerings
Table 72. BAHE Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. BAHE Key News & Latest Developments
Table 74. Harbin Fuerjia Technology Company Summary
Table 75. Harbin Fuerjia Technology Recombinant Type III Collagen Product Offerings
Table 76. Harbin Fuerjia Technology Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Harbin Fuerjia Technology Key News & Latest Developments
Table 78. Beijing Duomeikang Medical Science and Technology Company Summary
Table 79. Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Product Offerings
Table 80. Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Beijing Duomeikang Medical Science and Technology Key News & Latest Developments
Table 82. Yangzhou Meirui Biology Company Summary
Table 83. Yangzhou Meirui Biology Recombinant Type III Collagen Product Offerings
Table 84. Yangzhou Meirui Biology Recombinant Type III Collagen Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Yangzhou Meirui Biology Key News & Latest Developments
Table 86. Recombinant Type III Collagen Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Recombinant Type III Collagen Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Recombinant Type III Collagen Production by Region, 2018-2023 (K Units)
Table 89. Global Recombinant Type III Collagen Production by Region, 2024-2029 (K Units)
Table 90. Recombinant Type III Collagen Market Opportunities & Trends in Global Market
Table 91. Recombinant Type III Collagen Market Drivers in Global Market
Table 92. Recombinant Type III Collagen Market Restraints in Global Market
Table 93. Recombinant Type III Collagen Raw Materials
Table 94. Recombinant Type III Collagen Raw Materials Suppliers in Global Market
Table 95. Typical Recombinant Type III Collagen Downstream
Table 96. Recombinant Type III Collagen Downstream Clients in Global Market
Table 97. Recombinant Type III Collagen Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Type III Collagen Segment by Type in 2022
Figure 2. Recombinant Type III Collagen Segment by Application in 2022
Figure 3. Global Recombinant Type III Collagen Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Type III Collagen Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Type III Collagen Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Type III Collagen Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Type III Collagen Revenue in 2022
Figure 9. By Type - Global Recombinant Type III Collagen Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Type III Collagen Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Type III Collagen Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Type III Collagen Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Type III Collagen Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Type III Collagen Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 23. US Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 37. China Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Type III Collagen Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Type III Collagen Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Type III Collagen Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Type III Collagen Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Type III Collagen by Region, 2022 VS 2029
Figure 54. Recombinant Type III Collagen Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 遺伝子組み換えコラーゲン医療美容注射のグローバル市場展望 2023年-2029年：植物由来コラーゲン、動物由来コラーゲン
  • 組換えカスケード試薬（rCR）＆組換えファクターCのグローバル市場展望 2023年-2029年：リコンビナントファクターC、リコンビナントカスケード試薬（rCR）
  • 組換えリムルス＆組換えファクターC試薬のグローバル市場展望 2023年-2029年：組換えリムルス試薬、組換えファクターC
  • 組換えヒトパピローマウイルス9価ワクチンのグローバル市場展望 2023年-2029年：女性、男性
  • 組換え活性型凝固第VII因子のグローバル市場展望 2023年-2029年：バイアル、プレフィルドシリンジ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC13748 )"組換えIII型コラーゲンのグローバル市場展望 2023年-2029年：組換えIII型コラーゲンフリーズドライファイバー、組換えIII型コラーゲン複合ドレッシング、組換えIII型コラーゲンジェル、その他" (英文：Recombinant Type III Collagen Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。